טוען...
Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
Temozolomide (TMZ) is an alkylating agent used in the treatment of high-grade malignant glioma, notably glioblastoma multiforme, the most aggressive form of brain cancer. The drug induces a dozen DNA methylation adducts, including O(6)-methylguanine (O(6)MeG), which is the most toxic primary DNA les...
שמור ב:
| הוצא לאור ב: | Int J Mol Sci |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
MDPI
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6480213/ https://ncbi.nlm.nih.gov/pubmed/30925722 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20071562 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|